Efficacy of Extracorporeal Shockwave Therapy on Calcified and Noncalcified Shoulder Tendinosis: A Propensity Score Matched Analysis
Table 2
Pain score and functional outcomes one year after ESWT.
Clinical assessment
NCTS
TCTS
DCTS
P value
=20
=20
=20
VAS
Before Tx (SD; range)
5.5 ± 0.76(4-7)
5.4 ± 1.04(2-8)
5.4 ± 0.94(3-7)
.944
After Tx (SD; range)
2.9 ± 2.86(0-9)
1.5 ± 2.48(0-6)
3.8 ± 2.46(0-6)
.011
P value
.001
<.001
.020
Pain score
Before Tx (SD; range)
4.6 ± 0.88(2-6)
4.1 ± 1.00(2-6)
4.6 ± 0.60(3-5)
.091
After Tx (SD; range)
7.7 ± 2.13(3-10)
8.8 ± 2.00(4-10)
6.5 ± 2.16(4-10)
.004
P value
.001
<.001
.003
Night pain
Before Tx (SD; range)
2.6 ± 0.83(1-4)
2.6 ± 0.94(1-4)
2.6 ± 0.50(2-3)
.985
After Tx (SD; range)
4.2 ± 1.04(2-5) §
4.3 ± 1.13(2-5)
3.3 ± 1.20(2-5)
.012
Strength
<.001
<.001
.030
Before Tx (SD; range)
12.6 ± 3.66(5-20)
11.2 ± 3.23(5-16)
12.7 ± 3.08(7-18)
.349
After Tx (SD; range)
19.2 ± 5.22(8-25)
22.4 ± 5.10(8-25)
18.4 ± 4.69(10-25)
.002
P value
<.001
<.001
.001
Activity
Before Tx (SD; range)
10.8 ± 3.16(5-5)
10.0 ± 2.51(6-16)
10.7 ± 2.56(6-16)
.626
After Tx (SD; range)
16.1 ± 4.16(10-23) §
17.6 ± 4.24(6-20)
14.7 ± 4.13(8-20)
.031
P value
.001
<.001
.002
Motion
Before Tx (SD; range)
22.0 ± 8.41(8-34)
21.9 ± 7.99(6-36)
23.3 ± 5.20(16-36)
.721
After Tx (SD; range)
31.7 ± 7.18(14-38)
33.9 ± 7.77(16-40)
28.3 ± 7.06(18-40)
.030
P value
.002
<.001
.005
Constant
Before Tx (SD; range)
52.5 ± 14.5(21-74)
49.7 ± 9.03(33-62)
53.8 ± 7.66(42-64)
.409
After Tx (SD; range)
78.7 ± 18.3(38-98)
86.9 ± 19.7(40-100)
71.1 ± 17.8(44-98)
.007
P value
.001
<.001
.001
p < 0.05 versus TCTS (calcified tendinitis types II and III). § p < 0.05 versus DCTS(calcified tendinitis type I). NCTS: noncalcified tendonosis of shoulder. TCTS: calcified tendinosis type II and III of shoulder. DCTS: calcified tendinosis type I of shoulder.
